headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A
registered company in England and Wales: 09823909. | Terms and conditions
Will GSK’s new ‘ethical’ approach to its customers deliver commercial success?
In a bid to overcome stubborn industry-wide challenges, improve external perceptions and build stronger relationships with customers, GSK has made innovative changes to age-old, traditional commercial processes.
In this whitepaper we explore the new GSK commercial model and reflect on the impact it’s having on the industry as a whole. Will this new approach become common practice? Find out more by downloading your free copy today >>>
With expert contributions from:
Murray Stewart, Chief Medical Officer, GSK
Deborah Waterhouse, SVP and Business Unit Head, GSK
Denise Dewar, Head of MCM Excellence, GSK
Victoria Williams, VP and Sales Director, GSK FR
John Lamattina, former President, Pfizer
Stewart Adkins, financial analyst and Director, Pharmaforensic
Christopher Bowe, award-winning writer
Jack Whelan, cancer survivor and sales expert
Discover how GSK’s business model will change pharma forever, download your copy today >>>